WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark ELEVIDYS was filed as Word mark on 10/13/2020 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 1576513 |
| Countries | 
|
| Base trademark |
No. 88886693,
April 24, 2020
|
| Application date | October 13, 2020 |
| Expiration date | October 13, 2030 |
Trademark owner
215 First Street
Cambridge MA 02142
US
Cambridge MA 02142
US
Trademark representatives
3724 Benson Drive
Raleigh NC 27609
US
goods and services
05
Pharmaceutical preparations for the treatment of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders; pharmaceutical preparations based on
morpholino oligomer technology platform for the treatment of
neuromuscular diseases and disorders, muscular dystrophies,
central nervous system diseases and disorders, genetic
diseases and disorders, and for the regulation of protein
production; pharmaceutical preparations that modulate rna
expression for the treatment of neuromuscular diseases and
disorders, muscular dystrophies, central nervous system
diseases and disorders, genetic diseases and disorders, and
for the regulation of protein production; gene therapy
products, namely, gene delivery pharmaceuticals;
pharmaceutical preparations for gene therapy, gene editing,
and genome editing; gene therapy products for the treatment
of neuromuscular diseases and disorders, muscular
dystrophies, central nervous system diseases and disorders,
genetic diseases and disorders; biological preparations for
the treatment of neuromuscular diseases and disorders,
muscular dystrophies, central nervous system diseases and
disorders, genetic diseases and disorders; viruses, viral
vectors and viral constructs, all of the foregoing used as
delivery agents, for the treatment of neuromuscular diseases
and disorders, muscular dystrophies, central nervous system
diseases and disorders, genetic diseases and disorders;
pharmaceutical preparations, biological preparations and
gene therapy products in the nature of pharmaceutical and
biological preparations for the treatment of genetic
disorders and diseases
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| August 2, 2023 | 2023/31 Gaz | PK | Rejection |
| July 24, 2023 | 2023/30 Gaz | MY | Rejection |
| July 14, 2023 | 2023/29 Gaz | TM | Rejection |
| July 5, 2023 | 2023/27 Gaz | TH | Rejection |
| July 5, 2023 | 2023/27 Gaz | KH | Rejection |
| April 4, 2023 | 2023/16 Gaz | TJ | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| March 28, 2023 | 2023/13 Gaz | TT | Rejection |
| March 23, 2023 | 2023/13 Gaz | AL | Rejection |
| March 13, 2023 | 2023/11 Gaz | GE | Rejection |
| February 13, 2023 | 2023/7 Gaz | CU | Rejection |
| February 10, 2023 | 2023/7 Gaz | UA | Rejection |
| February 9, 2023 | 2023/6 Gaz | VN | Rejection |
| February 1, 2023 | 2023/5 Gaz | LI | Rejection |
| January 31, 2023 | 2023/5 Gaz | SG | Rejection |
| January 24, 2023 | 2023/5 Gaz | CO | Rejection |
| January 20, 2023 | 2023/4 Gaz | AM | Rejection |
| January 12, 2023 | 2023/2 Gaz | ME | Rejection |
| January 3, 2023 | 2023/1 Gaz | MD | Rejection |
| January 2, 2023 | 2023/1 Gaz | ID | Rejection |
| December 12, 2022 | 2022/52 Gaz | MN | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| November 28, 2022 | 2022/48 Gaz | OA | Rejection |
| November 22, 2022 | 2022/47 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| November 3, 2022 | 2022/45 Gaz | SX | Rejection |
| November 3, 2022 | 2022/44 Gaz | IL | Rejection |
| November 1, 2022 | 2022/44 Gaz | KG | Rejection |
| October 25, 2022 | 2022/44 Gaz | IR | Rejection |
| October 25, 2022 | 2022/44 Gaz | TJ | Rejection |
| October 20, 2022 | 2022/42 Gaz | KZ | Rejection |
| October 16, 2022 | 2022/42 Gaz | DZ | Rejection |
| October 4, 2022 | 2022/40 Gaz | NZ | Rejection |
| September 28, 2022 | 2022/39 Gaz | SM | Rejection |
| September 26, 2022 | 2022/42 Gaz | IN | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| September 23, 2022 | 2022/39 Gaz | CW | Rejection |
| August 29, 2022 | 2022/38 Gaz | MN | Rejection |
| August 22, 2022 | 2022/34 Gaz | RS | Rejection |
| August 20, 2022 | 2022/34 Gaz | AU | Rejection |
| July 26, 2022 | 2022/31 Gaz | CO | Rejection |
| July 21, 2022 | 2022/29 Gaz | BY | Rejection |
| July 15, 2022 | 2023/23 Gaz | IS | Rejection |
| June 22, 2022 | 2022/25 Gaz | CA | Rejection |
| June 11, 2022 | 2022/24 Gaz | PH | Rejection |
| June 3, 2022 | 2022/23 Gaz | MX | Rejection |
| April 12, 2022 | 2022/15 Gaz | BA | Rejection |
| April 7, 2022 | 2022/15 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| April 5, 2022 | 2022/14 Gaz | MC | Rejection |
| March 18, 2022 | 2022/12 Gaz | KR | Rejection |
| January 12, 2022 | 2022/2 Gaz | NO | Rejection |
| January 11, 2022 | 2022/4 Gaz | US | Correction |
| January 11, 2022 | 2022/2 Gaz | CH | Rejection |
| January 3, 2022 | 2022/1 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| December 16, 2021 | 2021/50 Gaz | JP | Rejection |
| November 16, 2021 | 2021/47 Gaz | BR | Rejection |
| June 30, 2021 | 2021/26 Gaz | GB | Rejection |
| June 16, 2021 | 2021/24 Gaz | CN | Rejection |
| June 9, 2021 | 2021/23 Gaz | TR | Rejection |
| May 31, 2021 | 2021/22 Gaz | RU | Rejection |
| March 8, 2021 | 2021/11 Gaz | IN | Rejection |
| October 13, 2020 | 2021/5 Gaz | US | Registration |
ID: 141576513